Vc Thoughts, Health, Dna, Rna, Healthcare.
limits the range of treatable diseases. Three pre-clinical companies and one clinical company actively developing solutions to address this challenge are AAVantgarde Bio, SpliceBio, Akouos, and Vector Biopharma. AAVantgarde Bio is working on two technologies that use protein splicing to reduce the